Anterogen Co Ltd
Name:
Anterogen Co Ltd
Stock Code:
Updating...
Head Office:
Updating...
Tel:
Updating...
Fax:
Updating...
E-mail:
Updating...
Year of establishment:
Updating...
Industry:

Introduction


Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Information is being updated

You need to login to view information

Charter capital

You must be a member to view the information

Business Size and Operations

Total Assets

A10 (Bellow 100 B) A9 (100 - 200 B) A8 (200 - 400 B) A7 (400 - 600 B) A6 (600 - 800 B)
A5 (800 - 1000 B) A4 (1000 - 1500 B) A3 (1500 - 2000 B) A2 (2000 - 2500 B) A1 (Above 2500 B)

Owner’s Equity

E10 (Bellow 100 B) E9 (100 - 200 B) E8 (200 - 400 B) E7 (400 - 600 B) E6 (600 - 800 B)
E5 (800 - 1000 B) E4 (1000 - 1500 B) E3 (1500 - 2000 B) E2 (2000 - 2500 B) E1 (Above 2500 B)

Revenue

R10 (Bellow 100 B) R9 (100 - 200 B) R8 (200 - 400 B) R7 (400 - 600 B) R6 (600 - 800 B)
R5 (800 - 1000 B) R4 (1000 - 1500 B) R3 (1500 - 2000 B) R2 (2000 - 2500 B) R1 (Above 2500 B)

Number of employee

L10 (Bellow 100 Peoples) L9 (100 - 200 Peoples) L8 (200 - 400 Peoples) L7 (400 - 600 Peoples) L6 (600 - 800 Peoples)
L5 (800 - 1000 Peoples) L4 (1000 - 1500 Peoples) L3 (1500 - 2000 Peoples) L2 (2000 - 2500 Peoples) L1 (Above 2500 Peoples)

Company’s Market Position

Return on Total Assets (ROA)

Bottom 25% 25%-m m-25% Top 25%

Return on Equity (ROE)

Net Profit Margin (ROS)

Bottom 25% 25%-m m-25% Top 25%
Bosttom 25% 25%-m m-25% Top 25%
n = 0 m(ROA) = m(ROE) =
No data found